Radiopharmaceuticals : progress and clinical perspectives /

Radiopharmaceuticals : progress and clinical perspectives /

42

Detalhes bibliográficos
Autor principal:	Fritzberg, Alan R.
Formato:
Publicado em:	Boca Raton, Fla. : CRC Pr, 1986
Assuntos:	Radiopharmaceuticals

Registos relacionados

Radiopharmaceuticals for positron emission tomography /
Por: Scott, Peter J. H., et al.
Publicado em: (c201)

Radiopharmaceuticals and other compounds labelled with shortlived radionuclides /
Por: Welch, Michael J.
Publicado em: (1977)

Radiopharmaceutical extravasations: a twenty year mini-review
Por: Dustin R. Osborne
Publicado em: (2023-07-01)

Radiopharmaceuticals from generator-produced radionuclides
Por: International Atomic Energy Agency
Publicado em: (1971)

Adverse reactions to radiopharmaceuticals
Por: María del Val Gómez-Martínez, et al.
Publicado em: (2021-05-01)

Brief Analysis of the Validation of Analytical Methods for Radiopharmaceuticals
Por: Mengyi CHEN, et al.
Publicado em: (2024-12-01)

Planning a Clinical Development Programme for Radiopharmaceuticals: An Analysis of International Guidelines and Expertise
Por: D. V. Goryachev, et al.
Publicado em: (2025-02-01)

Regulation of Radiopharmaceutical Products
Por: V. V. Kosenko, et al.
Publicado em: (2022-12-01)

Pharmacokinetic Studies of Radiopharmaceuticals
Por: A. S. Lunev, et al.
Publicado em: (2022-12-01)

TO THE QUESTION OF RADIATION PROTECTION ENSURING OF PASSENGERS TAKEN RADIOPHARMACEUTICALS DURING TRANSPORTATION BY RAILWAY TRANSPORT
Por: N. N. Artemyeva, et al.
Publicado em: (2015-08-01)

Analytical and chromatographic technigues in radiopharmaceutical chemistry /
Por: Wieland, Donald M., et al.
Publicado em: (1986)

An overview of current phase 3 radiopharmaceutical therapy clinical trials
Por: Nicolas Lepareur, et al.
Publicado em: (2025-02-01)

Radiopharmaceuticals for Pancreatic Cancer: A Review of Current Approaches and Future Directions
Por: Sara Calistri, et al.
Publicado em: (2024-10-01)

Possible Impurities in Radiopharmaceuticals and Corresponding Test Methods
Por: G. E. Kodina, et al.
Publicado em: (2022-10-01)

The main issues of quality assurance of radiopharmaceuticals
Por: G. E. Kodina, et al.
Publicado em: (2019-12-01)

Concentration of Rhenium-188 for the Radiopharmaceutical Synthesis
Por: A. O. Malysheva, et al.
Publicado em: (2022-11-01)

QUALITY CONTROL OF RADIOPHARMACEUTICALS IN MEDICAL INSTITUTIONS
Por: G. E. Kodina, et al.
Publicado em: (2019-01-01)

RADIOPHARMACEUTICALS BASED ON THE GLUCOSE DERIVATIVES FOR TUMOR DIAGNOSIS
Por: R. V. Zeltchan, et al.
Publicado em: (2018-05-01)

Non-clinical Studies of Radiopharmaceuticals: Analysis of National and International Regulatory Practice (Review)
Por: O. E. Klementyeva, et al.
Publicado em: (2024-07-01)

Nano-Radiopharmaceuticals in Colon Cancer: Current Applications, Challenges, and Future Directions
Por: Ajnas Alkatheeri, et al.
Publicado em: (2025-02-01)

SYNTHESIS OF RADIOPHARMACEUTICAL WITH RHENIUM-188 AND LIPIODOL
Por: G. E. Kodina, et al.
Publicado em: (2019-01-01)

Methodological Approaches to Preclinical Evaluation of General Toxicity of Therapeutic Radiopharmaceuticals
Por: O. E. Klementyeva, et al.
Publicado em: (2021-12-01)

Selection and Use of Antioxidants-radioprotectors in the Composition of Therapeutic Radiopharmaceuticals (Review)
Por: E. P. Pavlenko, et al.
Publicado em: (2023-12-01)

Analysis of Current Rules and Regulations for Preclinical Studies of Radiopharmaceuticals
Por: A. S. Lunev, et al.
Publicado em: (2024-02-01)

Peculiarities of the Regulatory Status of Radiopharmaceuticals Manufactured in Medical Organisations
Por: S. V. Shatik, et al.
Publicado em: (2022-12-01)

Non-[<sup>18</sup>F]FDG PET-Radiopharmaceuticals in Oncology
Por: Antonia Dimitrakopoulou-Strauss, et al.
Publicado em: (2024-12-01)

Operational guidance on hospital radiopharmacy : a safe and effective approach [electronic resource] /
Por: International Atomic Energy Agency
Publicado em: (2008)

Operational guidance on hospital radiopharmacy : a safe and effective approach /
Por: International Atomic Energy Agency
Publicado em: (2008)

Radiosynthesis and Preclinical Evaluation of [<sup>99m</sup>Tc]Tc-Tigecycline Radiopharmaceutical to Diagnose Bacterial Infections
Por: Syeda Marab Saleem, et al.
Publicado em: (2024-09-01)

Radiation Absorbed Dose Evaluation of [177Lu] Lu-DOTMP Radiopharmaceutical in Man Based On Biodistribution Data in Wistar Rats
Por: Reza Bagheri, et al.
Publicado em: (2024-12-01)

Experience in Validation of Methods for Determination of Radiochemical Impurities in Radiopharmaceuticals
Por: A. O. Malysheva, et al.
Publicado em: (2020-12-01)

Prostate-specific membrane antigen-targeting radiopharmaceuticals: a new frontier in hepatic malignancies
Por: Fucen Liu, et al.
Publicado em: (2025-03-01)

Can ChatGPT help patients understand radiopharmaceutical extravasations?
Por: Madeleine Alvarez
Publicado em: (2024-11-01)

[89Zr]Zr-DFO-TOC: a novel radiopharmaceutical for PET imaging of somatostatin receptor positive neuroendocrine tumors
Por: Alexis M. Sanwick, et al.
Publicado em: (2024-12-01)

Personalized metronomic radiopharmaceutical therapy through injection profile optimization via physiologically based pharmacokinetic (PBPK) modeling
Por: Aryan Golzaryan, et al.
Publicado em: (2025-02-01)

Results of individual dosimetric monitoring of the hands skin for personnel engaged in working with radiopharmaceuticals
Por: E. N. Shleenkova, et al.
Publicado em: (2025-01-01)

About the requirements of regular monitoring of doses for the eye lens of the staff working with radiopharmaceuticals
Por: E. N. Shleenkova, et al.
Publicado em: (2021-10-01)

An Insight to Nanoliposomes as Smart Radiopharmaceutical Delivery Tools for Imaging Atherosclerotic Plaques: Positron Emission Tomography Applications
Por: Reabetswe Sebatana, et al.
Publicado em: (2025-02-01)

Radioactivity distribution in the blood and urine of patients receiving systemic therapy with a <sup>177</sup>Lu radiopharmaceutical and local (intra-articular) therapy with a <sup>188</sup>Re radiopharmaceutical
Por: E. D. Stepchenkova, et al.
Publicado em: (2022-12-01)

Comparison of the dosimetry and cell survival effect of 177Lu and 161Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases
Por: Laura De Nardo, et al.
Publicado em: (2024-11-01)